Jonathan Perez

Program: Immunology

Current advisor: Daniel Kreisel, MD, PhD

Undergraduate university: Johns Hopkins University, 2022

Enrollment year: 2024

Research summary
Exploring mechanisms of immune cell mediated damage to pulmonary and cardiac grafts resulting from alloimmunity and/or ischemia reperfusion injury.

My primary project thus far has been exploring the regulation of cell death by p53 in ischemia reperfusion injury (IRI) after heart transplantation. Prior studies have from our lab have demonstrated that p53 is necessary for recruitment of neutrophils to the graft following IRI. My goal has been exploring the mechanism for this and specifically which cell death pathways are affected. We aim to identify other targets that, through pharmacologic inhibition, could attenuate the effects of IRI and therefore improve graft function.

Graduate publications
Mineura K, Liu CR, Amrute JM, Kawana S, Elmenshawy FH, Perez JL, Lounsbery-Scaife W, Poddar N, Nunna V, Li W, Terada Y, Meadows A, Heo GS, Wang W, Davighi MG, Morla-Folch J, Park S, Laghlali G, Burgess E, Schotsaert M, Liu Y, Lavine KJ, Ritter JH, Lama VN, Brody SL, Nava RG, Gelman AE, Krupnick AS, Perez-Rodriguez L, Hasson D, Teunissen AJP, Ochando J, Kreisel D. 2026 Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation. Am J Transplant, S1600-6135(26):02582-7. PMCID: